Ultra Low Dose CT for CACS and AC of SPECT

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 105 participants.

Also called NCT02458352

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose diagnostic
Phase
Not applicable
Enrolled
  • 105 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02458352
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
Switzerland (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02458352. Allocation not applicable; no masking; primary purpose diagnostic. Start 2015-11 (registry gives no type); primary completion 2016-10 (actual). Results posted on 2019-10-18.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Ultra Low Dose CT for CACS and AC of SPECT
Intervention (Device)
Ultra low dose non-contrast enhanced CT
Intervention (Device)
Standard dose non-contrast enhanced CT
Lead sponsor
University of Zurich (class: other)

Record details

Record id
cardio:ct-nct02458352
Content hash
9598d326124a83f884bdf169221123d23e69b11f913b3cd89095f88098762105